MBRS-34. MOLECULAR CHARACTERIZATION OF RECURRENT MEDULLOBLASTOMA REVEALS AN UNEXPECTEDLY HIGH INCIDENCE OF SECONDARY MALIGNANCY

INTRODUCTION: Despite an overall 5-year progression free survival of approximately 80% for primary medulloblastomas (MBs), recurrent disease confers an abysmal prognosis with less than 10% 5-year survival. Subgroup affiliation at recurrence has been reported as stable though divergent clonal selecti...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Neuro Oncol
Main Authors: Kumar, Rahul, Deng, Maximilian, Rudneva, Vasilisa A, Robinson, Giles W, Dhall, Girish, Klesse, Laure J, Bowers, Daniel C, Chintagumpala, Murali, Leary, Sarah, Orr, Brent A, Pfister, Stefan M, Gajjar, Amar, Jones, David T W, Northcott, Paul A
פורמט: Artigo
שפה:Inglês
יצא לאור: Oxford University Press 2018
נושאים:
Abstracts
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012936/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.479
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים